(Adnkronos) - “Sistemi a lenti rilascio” al posto dei colliri “diagnosi il più possibile cellulare e nuove tecniche chirurgiche, sempre meno invasive, che trovano un posto all'interno del percorso di cura del glaucoma sempre meno finale” hanno “rivoluzionato” il trattamento di questa malattia del nervo ottico dovuta a un aumento della pressione intraoculare. Lo ha detto Stefano Gandolfi, direttore della Clinica Oculistica dell'Università di Parma, past president Società italiana glaucoma (Sigla) ricordando gli argomenti principali del congresso della Siso, Società italiana scienze oftalmologiche.
Category
🗞
NewsTranscript
00:00As for the glaucoma, we have talked about slow-release systems, we have also talked about systems that allow the most possible cellular diagnosis,
00:24that is, when the disease affects the single cell, and then there has been a lot of talk about new surgical techniques, increasingly less invasive,
00:34which find a place within the glaucoma treatment path, increasingly less final.
00:47Usually surgery is put at the end, it is the sentence that comes to the patient when everything has failed. With these techniques, surgery is recovered and offered and proposed in the initial stages of the disease.
01:02Two, the drops. There is a lot of work on what? On the development of different ways to get medicine into the eye, that is, no longer using the collar as a vehicle, but, for example, supplying slow-release systems
01:24that, through a supply, last a month or months, or through a micro-injection into the eye itself, allow for several months to go on with controlled pressure.